Latest Stock Split Details
Key information about Acorda Therapeutics, Inc.'s most recent stock split
Developer API
Get ACOR split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 20.00 times fewer shares (a 1:20 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Acorda Therapeutics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2023-06-05 | 1:20 | Yes | $0.08 | $0.00 |
| 2021-01-04 | 1:6 | Yes | $0.11 | $0.02 |
About Acorda Therapeutics, Inc.
Company overview and industry information
Acorda Therapeutics, Inc. (ACOR) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.